Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/132624
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBerasategui, Barbara-
dc.contributor.authorFonollosa, Alex-
dc.contributor.authorArtaraz, Joseba-
dc.contributor.authorRuiz Arruza, Ioana-
dc.contributor.authorRíos, José-
dc.contributor.authorMatas, Jessica-
dc.contributor.authorLlorenç, Victor-
dc.contributor.authorDíaz Valle, David-
dc.contributor.authorSastre Ibanez, Marina-
dc.contributor.authorArriola Villalobos, Pedro-
dc.contributor.authorAdán Civera, Alfredo-
dc.date.accessioned2019-05-03T09:56:40Z-
dc.date.available2019-05-03T09:56:40Z-
dc.date.issued2018-07-20-
dc.identifier.issn1471-2415-
dc.identifier.urihttp://hdl.handle.net/2445/132624-
dc.description.abstractBackground: Hyperreflective foci have been described in OCT imaging of patients with retinal vascular diseases. It has been suggested that they may play a role as a prognostic factor of visual outcomes in these diseases. The purpose of this study is to describe the presence of hyperreflective foci in patients with non-infectious uveitic macular edema and evaluate their behavior after treatment. Methods: We conducted a multicenter, prospective, observational, 12-month follow-up study. Inclusion criteria were age > 18 years and a diagnosis of non-infectious uveitic macular edema, defined as central macular thickness of > 300 mu m as measured by OCT and fluid in the macula. Collected data included best corrected visual acuity, central macular thickness and the presence, number and distribution (inner or outer retinal layers) of hyperreflective foci. Evaluations were performed at baseline, and at 1, 3, 6, and 12 months after starting treatment. Results: We included 24 eyes of 24 patients. The frequency of patients with >= 11 hyperreflective foci was 58.4% at baseline, falling to 20.8% at 12 months. Further, hyperreflective foci were observed in the outer retinal layers in 50% of patients at baseline and just 28.6% at 12 months. Mean LogMAR visual acuity improved from 0.55 (95% CI 0.4-0. 71) at baseline to 0.22 (95% CI 0.08-0.35) at 12 months (p < 0.001). Mean central macular thickness decreased from 453.83 mu m (95% CI 396.6-511) at baseline to 269.32 mu m (95% CI 227.7-310.9) at 12 months (P < 0.001). Central macular thickness was associated with number (p = 0.017) and distribution (p = 0.004) of hyperreflective foci. Conclusions: We have observed hyperreflective foci in most of our patients with non-infectious uveitic macular edema. During follow-up and after treatment, the number of foci diminished and they tended to be located in the inner layers of the retina.-
dc.format.extent10 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s12886-018-0848-5-
dc.relation.ispartofBMC Ophthalmology, 2018, vol. 18, num. 1, p. 179-188-
dc.relation.urihttps://doi.org/10.1186/s12886-018-0848-5-
dc.rightscc-by (c) Berasategui, Barbara et al., 2018-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)-
dc.subject.classificationMicròglia-
dc.subject.classificationOftalmopaties-
dc.subject.classificationMalalties de la retina-
dc.subject.classificationPronòstic mèdic-
dc.subject.otherMicroglia-
dc.subject.otherOphthalmopathies-
dc.subject.otherRetinal diseases-
dc.subject.otherPrognosis-
dc.titleBehavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec687862-
dc.date.updated2019-05-03T09:56:40Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid30029623-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
687862.pdf1.07 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons